Annuncio pubblicitario
Italia markets closed
  • Dow Jones

    39.069,23
    -62,30 (-0,16%)
     
  • Nasdaq

    15.976,25
    -20,57 (-0,13%)
     
  • Nikkei 225

    39.233,71
    +135,03 (+0,35%)
     
  • EUR/USD

    1,0852
    +0,0029 (+0,27%)
     
  • Bitcoin EUR

    50.451,05
    +2.757,18 (+5,78%)
     
  • CMC Crypto 200

    885,54
    0,00 (0,00%)
     
  • HANG SENG

    16.634,74
    -91,12 (-0,54%)
     
  • S&P 500

    5.069,53
    -19,27 (-0,38%)
     

Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner

Chr. Hansen Holding A/S
Chr. Hansen Holding A/S

DECEMBER 12, 2022 – ANNOUNCEMENT NO. 13

Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The combination is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.


Please see attachment.


CONTACT INFORMATION

Novozymes:

Investor Relations
Tobias Cornelius Björklund
+45 3077 8682
tobb@novozymes.com

Chr. Hansen:

Investor Relations
Anders Mohr Christensen
+45 2515 2364
dkamc@chr-hansen.com

 

Press Relations
Lina Danstrup
+45 3077 0552
lind@novozymes.com

Press Relations
Sanne Seyer-Hansen
+45 6038 6207
dksash@chr-hansen.com

Attachment